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Abstract
Background: Dracaena cinnabari (DC) is a perennial tree that located on the Southern coast of Yemen native to
the Socotra Island. This tree produces a deep red resin known as the Dragon’s blood, the Twobrother’s Blood or
Damm Alakhwain. The current study performed to evaluate the safety of the DC resin methanol extract after a
single or 28 consecutive daily oral administrations.
Methods: In assessing the safety of DC resin methanol extract, acute and sub-acute oral toxicity tests performed
following OECD guidelines 423 and 407, respectively, with slight modifications. In acute oral toxicity test, DC resin
methanol extract administered to female Sprague Dawley rats by oral gavage at a single dose of 300 and 2000 mg/kg
body weight. Rats observed for toxic signs for 14 days. In sub-acute oral toxicity test, DC resin methanol extract
administered to the rats by oral gavage at 500, 1000, and 1500 mg/kg body weight daily up to 28 days to male and
female Spradgue Dawley rats. The control and high dose in satellite groups were also maintained and handled as the
previous groups to determine the late onset toxicity of DC resin methanol extract. At the end of each test, hematological
and biochemical analysis of the collected blood were performed as well as gross and microscopic pathology.
Results: In acute oral toxicity, no treatment-related death or toxic signs were observed. It revealed that the DC resin
methanol extract could be well tolerated up to the dose 2000 mg/kg body weight and could be classified as Category 5.
The sub-acute test observations indicated that there are no treatment-related changes up to the high dose level
compared to the control. Food consumption, body weight, organ weight, hematological parameters, biochemical
parameters and histopathological examination (liver, kidney, heart, spleen and lung) revealed no abnormalities.
Water intake was significantly higher in the DC resin methanol extract treated groups compared to the control.
Conclusion: This study demonstrates tolerability of DC resin methanol extract administered daily for 28 days up to
1500 mg/kg dose.
Keywords: DC resin methanol extract, Acute oral toxicity, Sub-acute oral toxicity, Histopathology,
Hematological parameters, Biochemical parameters
Background
Medicinal plants are used worldwide to treat many dis-
eases, and new drugs continue to be developed through
research from these plants [1]. Medicinal plant prepara-
tions can be formulated into many forms including liq-
uids, and they have been used worldwide for many years
[2]. The use of a medicinal plant for the treatment of
disease without the scientific foundation to adequately
support conclusions of safety and efficacy can be poten-
tially dangerous as well as useless. In addition, misuse of
these medicinal plants may cause serious toxicity for
humans [3]. As chemical compositions of the medicinal
plant are complex, some moderate to severe side effects
may arise from the use of herbal medicines. Therefore, it
is important to establish medicinal plant safety through
the use of well-controlled and validated scientific toxicity
studies or protocols [4].* Correspondence: aied_absi@yahoo.com2Department of Oral Biology and Biomedical Sciences, Faculty of Dentistry,
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Toxicological studies subjected to make a decision
about whether a new drug should be accepted for clin-
ical use or not [5]. Toxicity study gives information on
toxic doses and therapeutic indices of drugs and xeno-
biotic [6]. The outcome of the toxicity study in animals
is vitally needed to determine the safety of medicinal
plants if they are found to be suitable for development
into pharmacological products. In addition, to determine
the appropriate dose for long-term toxicity tests and to
determine the affected organs at the end of the treatment,
the toxicity test is achieved [7]. It is a scientific, ethical
and regulatory requirement that before any potential new
medicine administered to humans, its safety must be
investigated in animals to define safe human doses [8].
Dracaena cinnabari (DC) is a perennial tree located
on the Southern coast of Yemen native to the Socotra
Island. This tree produces a deep red resin which called
the Dragon’s blood or the Twobrother’s Blood [9]. DC
belongs to Agavaceae family, which is commonly known
as Damm Alakhwain in Yemen [10]. It is a large, single-
trunked tree with height up to 10 m and smooth grey
bark. Branches with sausage-shaped sections form an
umbrella-shaped crown [11]. DC tree populations on
Socotra do not regenerate to a significant extent, and
their age structure indicates overmaturity [12]. The red
“dragon’s blood” resin of the DC tree exudes from fis-
sures and wounds in the bark or branches [1]. People in
Socotra used the resin from DC for dying wool, glue
pottery, breath freshener, to decorate a pottery and
houses and even as lipstick [13]. In addition, DC resin
has been a famous traditional medicine since ancient
times in many cultures. It is used as an astringent for
treating diarrhea and dysentery as well as an antiseptic,
haemostatic and as an antiulcer remedy [1, 10, 14, 15].
Phytochemical studies of DC resin have led to the
isolation of several active compounds belonging to the
flavanoids, homoisoflavonoids, chalcones, sterols and
terpenoids. Some homoisoflavonoids and chalcones iso-
lated from the DC resin exhibited a strong antioxidant
activity [16]. The presence of flavonoids reported con-
tributing in anti-inflammatory activities of methanol ex-
tract of DC resin [17]. The chemical constituents of DC
resin have been reviewed by D Gupta, B Bleakley and
RK Gupta [1]. The methanolic extract of DC resin has
been reported to exert an antiviral activity against
Herpes simplex and Human influenza viruses [18]. DC
resin is showing enormous potential interaction with anti-
microbial [19] and antioxidants activities [10, 20] and con-
sidered as good source of food preservative due to its
inhibitory effect on various foodborne pathogens [20]. A
methanol extract of DC resin exhibited a non-specific in-
hibition of the parasites related to high cytotoxicity [21].
Despite its wide uses, no study has been done to know
about its oral toxicity which in turn will provide proper
safety information regarding DC resin and to define safe
human doses. Thus, the aim of the current study is to
evaluate the safety of the DC resin methanol extract after
a single or 28 consecutive daily oral administrations.
Methods
Preparation of Dracaena cinnabari (DC) resin extract
The resin of DC collected from Socotra Island (Yemen)
in May 2013. The plant samples were identified and au-
thenticated by Environmental Protection Authority of
Yemen. A voucher specimen of the resin (DC/2013-8/
122) has been deposited at the herbarium of department
of Pharmacognosy, Faculty of Pharmacy, University of
Sana’a, Yemen.
DC resin was ground into powder form using an elec-
trical blender to ease the extraction process. 50 g of the
powdered resin of DC placed into a 1 L conical flask
then macerated with methanol (500 ml methanol was
added in, where 1 g of dried and ground DC is to 10 ml
methanol) in the ratio of (1:10). Methanol has high po-
larity and thus greater efficacy towards the extraction of
polar phytochemicals such as phenolics and flavonoids
[22]. The conical flask was left at room temperature for
approximately 3 days on a shaker at 100 rpm. The re-
sultant extract filtered through a fine muslin cloth, and
then a filter paper Whatman (Grade 1-Circles, 150 mm)
was used to remove the crude part. For separating the
methanol from the extract, Eyela rotary evaporator used
under reduced pressure at 40 °C which produced a
gummy red resin extract. After that, a freeze dryer was
used to provide 28.0 g of a dry powder extract. The ex-
tract was then wrapped with aluminum foil to prevent a
photo-oxidation that might be occurred and was stored
at 4 °C until used. This methanol extract dissolved in
(10% DMSO) before use.
Experimental animals
Female and male Sprague Dawley (SD) rats were used
for the acute and sub-acute oral toxicology tests. Nine
rats (females) were used in an acute oral toxicity test,
whereas 60 rats (30 males and 30 females) used in sub-
acute oral toxicity test (the repeated dose 28 day). The
toxicity tests were carried out according to Organization
for Economic Cooperation and Development (OECD)
test guideline, i.e., OECD Guideline 423 for the acute
oral toxicity test [23] and OECD Guideline 407 for the
sub-acute oral toxicity test [24] with slight modifications.
The rats were obtained from the Animal Experimental
Unit, Faculty of Medicine, University of Malaya, Kuala
Lumpur. SD rats (8-10 weeks) weigh between 235 ± 15 g
were used. Prior to the start of the experiment, body
weight of animals was recorded individually for calculat-
ing proper treatment dosage. The volume was adjusted
depending on the body weight of the rat using 10 ml/kg
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as this is the normal volume to be used in the rat as
mentioned elsewhere [25, 26]. The female SD rats were
nulliparous and non-pregnant. The SD rats were given
standard rat pellets and reverse osmosis (RO) water ad
libitum. They were acclimatised to laboratory conditions
for 7 days before the experiments and housed in groups
of three for acute oral toxicity and in groups of five for
sub-acute oral toxicity. The rats were maintained at a
room temperature of 24 °C, with a 12 h light/dark
cycle. Protocols approved by the Institutional Animal
Care and Use Committee (IACUC), Faculty of Medi-
cine, University of Malaya, Malaysia (Ethics No. 2014-
02-14/OBBS/R/NAA). The endpoint of all rats consid-
ered when around 20% of body weight loss has been
shown.
Acute oral toxicity
The DC resin methanol extract was administered to the
female rats under overnight fasting by using oral gavage
in a volume of 10 ml/kg body weight.
Nine female SD rats were randomly divided into 3
groups of 3 rats each as mentioned previously [27].
The started dose at 300 mg/kg body weight of DC
resin methanol extract that dissolved in 10% DMSO
administered to the group 1. The rats were observed
for general behavioural changes; symptoms of toxicity
and mortality after treatment for the first 4 h, then
over a period of 48 h. Group 2 was administrated se-
quentially at 48-h intervals with the next higher dose
2000 mg/kg body weight of DC resin methanol ex-
tract that dissolved in 10% DMSO when there were
no signs of toxicity or mortality showed in group 1
after 48 h of treatment. In parallel, group 3 added
and treated with vehicle (10% DMSO) to establish a
comparative negative control group according to the
OECD guideline [23]. All animals observed at least
once during the first 30 min in the first 24 h with
great consideration given for the first 4 h following
vehicle or DC resin methanol extract administration
and then once a day for 14 days. This observation
was done to check the onset of clinical or toxico-
logical symptoms according to the OECD guideline
[23]. All observations included changes in skin and
fur, eyes and mucous membranes and behavioral pat-
tern were systematically recorded and maintained
with an individual record. In addition, consideration
was given for observations of convulsions, tremors,
diarrhea, salivation, lethargy, sleep, coma and mortal-
ity. The food consumption and water intake recorded
daily. The body weights of animals recorded shortly
before the administration of the tested substance and
at the end of each week. The percentage of body
weight change calculated according to the following
equation:
Body weight at the end of each week‐initial body weight
Initial body weight
 100
Sub-acute oral toxicity (repeated dose 28-day oral toxicity)
The SD rats were randomly divided into six groups of
10 rats each (n = 10/group, 5 males and 5 females) as
mentioned elsewhere [28]. Four groups were adminis-
tered daily with DC resin methanol extract at different
concentration dissolved in 10% DMSO and two groups
administered with the vehicle by using oral gavage.
Group 1 received vehicle (10% DMSO) and served as
control. Groups 2, 3 and 4 received doses of DC resin
methanol extract at 500, 1000 and 1500 mg/kg body
weight, respectively. The 5th and 6th groups namely sat-
ellite groups added to determine the reversibility or re-
covery from toxic effects of the test material and given
the vehicle (10% DMSO) and the top dose of DC resin
methanol extract 1500 mg/kg body weight, respectively.
They were handled as the previous groups. The test ma-
terial was administered orally (gavage) once daily for 28
consecutive days. The satellite groups were scheduled
for follow-up observations for the next 14 days without
a vehicle or DC resin methanol extract administration.
Mortality, food consumption and water intake, as well
as observation for general toxicity signs of the animals,
were monitored and recorded daily throughout the
study. The initial body weight of all the groups has been
recorded before the tested material is administered and
at the end of each week.
Hematology and serum biochemistry
At the end of each experiment (at 15th day for acute oral
toxicity and at 29th day for sub-acute oral toxicity tests
except the satellite groups which were at 43rd day), the
rats generally anesthetized by intraperitoneal injection of
80 mg/kg of ketamine 100 mg/ml + 7 mg/kg of xylazine
100 mg/ml (Troy Laboratories PTY. Limited, Smithfield,
Australia). Blood sample (5 ml) by cardiac puncture was
collected using a disposable syringe. The blood kept in
K2EDTA tube for analysing hematological parameters
[haemoglobin (HGB), white blood cell (WBC), Neutro-
phil, Lymphocyte, Monocyte, Eosinophil and Basophil]
and in Plain tubes for biochemical parameters [Urea,
Creatinine, Albumin, Globulin, Total bilirubin, Conju-
gate Bilirubin, Alkaline phosphatase (ALP), Alanine
transaminase (ALT) and Aspartate aminotransferase
(AST)]. The blood sample that placed in a plain tube left
for 15 - 20 min at room temperature to promote blood
coagulation. The blood sample was centrifuged at 5000
rpm for 20 min at 4 °C; the serum obtained then ana-
lysed. Immediately, after blood collection, rats were
sacrificed by cervical dislocation.
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Histopathological observation
Necropsy was done in acute and sub-acute oral toxicity
tests groups of animals on day 15 and 29 respectively,
and for the satellite groups, on day 43. After the blood
collection, rats were sacrificed by cervical dislocation,
and the vital organs (liver, kidney, heart, spleen and
lung) removed through a midline incision in the Rat’s
abdomen. The organs were cleaned of fat and blotted
with clean tissue paper, and then weighed on balance.
The relative organ’s weight (ROW) were calculated and
recorded in proportion to the body weight according to
the following equation:
RWO ¼ Absolute organ weight
Body weight at sacrifice
 100
Samples from the vital organs (liver, kidney, heart,
lung and spleen) of both acute and sub-acute oral tox-
icity tests were subjected to histopathological evaluation.
They fixed in 10% buffered formalin, routinely processed
and embedded in paraffin wax. Paraffin sections (5 μm)
was cut on glass slides and stained with hematoxylin and
eosin. An experienced pathologist who was unaware of
the experimental groups to which each section belonged
conducted the analysis. The slides were examined under
a light microscope (Nikon E50i, Nikon Corporation,
Japan) as mentioned elsewhere [29].
Statistical analysis
Results expressed as a mean ± standard deviation. The
differences between groups of acute and sub-acute tox-
icity tests determined by one-way analysis of variance
(ANOVA) followed by Tukey multiple comparison test,
and Student t test for satellite groups comparisons.
Differences were considered significant at p < 0.05.
Results
General sign and behavioral analysis
Oral administration of DC resin methanol extract
showed no treatment-related mortality in both sexes of
rats for both acute and sub-acute oral toxicity tests
throughout the study. Physical observation of the DC
treated rats for both acute and sub-acute oral toxicity
tests throughout this study indicated that none of them
showed signs of toxic effects such as changes in skin and
fur, eyes and mucous membrane, behavior pattern,
tremors, salivation, diarrhea and coma. No gross or
microscopic pathological abnormalities in all groups
(acute and sub-acute oral toxicity tests) observed in any
animals. Concerning the Globally Harmonized Classifi-
cation System, DC resin methanol extract can be classi-
fied as Category 5 and this provides direct relevance for
protecting animal and human health up to the high dose
level that used in this study.
Effect of DC extract on body weight, organ’s weight, food
consumption and water intake in acute and sub-acute
oral toxicity tests
A raw data of body weight, organ’s weight, food con-
sumption and water intake, is available in the
Additional file 1.
The body weight of the control and DC treated rats
were as shown in Table 1 (A and B). There was a
gradual increase in body weight of the control and
DC treated groups in both acute and sub-acute oral
toxicity tests. The percentage changes in body weight
of the DC treated groups were not significantly differ-
ent compared to the control rats as p > 0.05 (Table 1
A and B). In addition, there is no significant different
has been shown in Satellite groups in both sexes with
p > 0.05 (Table 2).
There was no statistically significant difference in
ROW between control and DC treated groups of both
tests as p > 0.05 (Table 3 A and B). No significant differ-
ent has been shown in Satellite group in both sexes as
p > 0.05 (Table 4).
The food consumption of the DC treated groups in
both tests was not significantly different compared to
the control group measured throughout the study as
p > 0.05 (Table 5 A and B) as well as in the satellite
groups in both sexes as p > 0.05 (Table 6).
The water intake of the control and DC treated
groups in acute oral toxicity test showed no significant
difference as p > 0.05 (Table 7 A) while in the sub-acute
oral toxicity test a significant difference has been dem-
onstrated between the control and DC treated groups
as p < 0.05 (Table 7 B). A post hoc Tukey test showed
significant differences between the DC treated (male
and female) and control groups as shown in Table 8 as
p < 0.05. Similarly, a significant difference has been
shown in Satellite groups between the DC treated
group and the control group in both sexes as p < 0.05
(Table 9).
Effect of DC extract on hematological parameters in acute
and sub-acute oral toxicity tests
A raw data of hematological parameters, is available in
the Additional file 1.
The hematological profile of control and DC treated
groups summarised in Table 10 (A and B). The re-
sults concluded that all hematological parameters
such as hemoglobin (HGB) and total white blood cell
count are within the normal range in both control
and DC treated groups. In ANOVA test, there is no
significant association between the groups in both
acute and sub-acute toxicity tests as p > 0.05. In the
satellite groups, there was no significant difference
showed in both sexes as p > 0.05 (Table 11).
Al-Afifi et al. BMC Complementary and Alternative Medicine  (2018) 18:50 Page 4 of 14
Effect of DC extract on serum biochemical parameters in
acute and sub-acute oral toxicity tests
A raw data of biochemical parameters, is available in the
Additional file 1.
The data on biochemical parameters in control and
DC treated groups of the acute oral toxicity test
presented in Table 12. There was no significant differ-
ence shown in the biochemical parameters between
groups as p > 0.05.
The data on biochemical parameters in control and
DC treated groups of sub-acute oral toxicity presented
in Table 13. There was no significant difference shown
in the biochemical parameters between the groups in
both sexes (male and female rat) as well as in the satel-
lite groups as p > 0.05 (Table 14).
Histopathological observation
A histopathological study carried to confirm biochemical
findings and to identify any structural changes. Light
microscopic examination of the vital organs including
liver, kidney, heart, lung and spleen of the rats in all the
DC treated and control groups for acute oral toxicity
(Fig. 1) and sub-acute oral toxicity (Fig. 2) did not reveal
any gross pathological lesions.
The photomicrographs of the liver and kidney of the
control and DC treated groups as well as of satellite
group, both male and female, showed with normal mor-
phological architecture. Under microscopic examination,
the liver of DC treated animals showed with normal cel-
lular architecture and binucleation and was without any
distortions similar to the control groups. Furthermore,
signs of injury, necrosis, congestion, fatty acid accumula-
tion, or hemorrhagic regions around the central vein or
sinusoids of the liver not observed. The hepatocytes ar-
ranged in cords and clearly visible. The cross-section of
the liver showed no lyses in the blood cells, or
Table 1 (A and B) Percentage of body weight gain of rats in acute and sub-acute oral toxicity tests at each week
A Acute oral toxicity
Sex Control DC 300 mg/kg DC 2000 mg/kg P value
0 day (g) F (n = 3) 235.33 ± 5.03 250.00 ± 8.54 249.67 ± 9.61
Week 1 (%) F (n = 3) 5.82 ± 1.44 4.92 ± 1.62 4.15 ± 0.37 0.340
Week 2 (%) F (n = 3) 8.65 ± 1.96 8.53 ± 1.59 7.37 ± 1.17 0.586
B Sub-acute oral toxicity
Sex Control DC 500 mg/kg DC 1000 mg/kg DC 1500 mg P value
0 day (g) M (n = 5) 232.00 ± 4.70 223.40 ± 5.22 226.40 ± 5.13 229.80 ± 3.96
F (n = 5) 247.20 ± 6.14 233.40 ± 2.70 228.60 ± 8.02 232.20 ± 2.56
Week 1 (%) M (n = 5) 8.28 ± 0.91 8.56 ± 0.79 8.11 ± 1.15 8.61 ± 1.28 0.853
F (n = 5) 5.03 ± 2.44 4.71 ± 1.09 5.44 ± 1.71 5.50 ± 2.21 0.907
Week 2 (%) M (n = 5) 16.73 ± 1.03 16.37 ± 1.19 16.78 ± 0.83 16.09 ± 1.87 0.811
F (n = 5) 7.53 ± 3.21 7.62 ± 2.09 7.27 ± 2.59 8.49 ± 2.30 0.889
Week 3 (%) M (n = 5) 24.25 ± 2.13 24.17 ± 1.09 23.69 ± 1.64 23.48 ± 2.00 0.881
F (n = 5) 11.42 ± 2.77 10.44 ± 2.82 10.55 ± 2.64 12.30 ± 3.20 .0715
Week 4 (%) M (n = 5) 29.34 ± 2.70 28.55 ± 1.60 29.71 ± 2.08 29.75 ± 4.94 0.920
F (n = 5) 13.83 ± 2.76 13.18 ± 2.24 13.36 ± 3.05 15.23 ± 2.94 0.649
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
Table 2 Satellite group/ Percentage of body weight change of
rats in sub-acute oral toxicity test
Satellite group/ Percentage of body weight change of rats in sub-acute
oral toxicity test
Sex Control DC 1500 mg/kg P value
0 day (g) M (n = 5) 229.20 ± 3.70 235.40 ± 3.85
F (n = 5) 222.20 ± 5.12 221.00 ± 6.67
Week 1 (%) M (n = 5) 8.38 ± 0.72 8.09 ± 1.21 0.657
F (n = 5) 4.86 ± 0.59 4.90 ± 1.54 0.960
Week 2 (%) M (n = 5) 15.36 ± 1.57 15.13 ± 0.77 0.782
F (n = 5) 7.57 ± 0.66 7.56 ± 1.67 0.994
Week 3 (%) M (n = 5) 19.90 ± 1.34 19.89 ± 1.62 0.988
F (n = 5) 10.09 ± 1.12 9.80 ± 1.68 0.756
Week 4 (%) M (n = 5) 24.45 ± 1.99 24.30 ± 0.83 0.883
F (n = 5) 12.96 ± 0.96 12.77 ± 1.35 0.807
Week 5 (%) M (n = 5) 28.81 ± 2.02 28.48 ± 1.68 0.788
F (n = 5) 15.22 ± 0.71 14.78 ± 1.81 0.631
Week 6 (%) M (n = 5) 34.03 ± 2.50 33.16 ± 2.69 0.612
F (n = 5) 17.28 ± 0.75 16.59 ± 1.65 0.415
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
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infiltration of neutrophil, lymphocyte, or macrophage in
the acute oral toxicity group and the sub-acute oral tox-
icity. For the kidneys, histologically there was no mor-
phological change for all DC treated groups. The
appearance of the glomerular architecture showed nor-
mal similar to the control groups. The glomeruli, distal,
and proximal tubules in the kidney appeared normal in
both male and female rats. In addition, there was no
interstitial and intraglomerular congestion or tubular
atrophies. All the nephron cells showed normal and
clearly visible nucleoli with no degeneration, bleeding, or
necrosis infiltration in acute oral toxicity group as well
as in the sub-acute oral toxicity. In both the control and
DC treated female and male rats, the heart shows nor-
mal cardiac muscle fibers and lungs show a normal al-
veolar structure with no treatment-related inflammatory
response in acute oral toxicity group as well as in the
sub-acute oral toxicity. Similarly, normal structure and
histology of the spleen also observed in all the rats of
acute and sub-acute oral toxicity tests. There is mild
congestion seen in the lung, liver, and kidney of the con-
trol and DC treated groups of both sexes which were in-
cidental or spontaneous with no relation to DC resin
methanol extraction treatment.
Thus, the histopathological evaluations of the selected
organs did not reveal any morphological abnormalities
that could be attributed to the oral administration of DC
resin methanol extract to the rats.
Discussion
Herbal medicines have acquired greater importance as a
substitute to conventional therapy [49]. As the use of
medicinal plants increases, screening plant products to
assess and evaluate the toxic characteristics of a natural
product extract, fraction, or compound consider an ini-
tial step [30].
Table 3 (A and B) Relative organs weight (g%) of rats in acute and sub-acute oral toxicity tests
A Acute oral toxicity
Sex Control DC 300 mg/kg DC 2000 mg/kg P value
Heart F (n = 3) 0.37 ± 0.02 0.35 ± 0.01 0.35 ± 0.03 0.422
Liver F (n = 3) 2.58 ± 0.14 2.60 ± 0.12 2.50 ± 0.13 0.601
Kidney F (n = 3) 0.70 ± 0.02 0.67 ± 0.03 0.68 ± 0.02 0.484
Spleen F (n = 3) 0.18 ± 0.02 0.18 ± 0.02 0.18 ± 0.01 0.952
Lung F (n = 3) 0.49 ± 0.01 0.48 ± 0.02 0.48 ± 0.02 0.874
B Sub-acute oral toxicity
Sex Control DC 500 mg/kg DC 1000 mg/kg DC 1500 mg/kg P value
Heart M (n = 5) 0.36 ± 0.02 0.35 ± 0.02 0.34 ± 0.02 0.34 ± 0.03 0.757
F (n = 5) 0.37 ± 0.02 0.37 ± 0.03 0.37 ± 0.02 0.38 ± 0.02 0.938
Liver M (n = 5) 2.92 ± 0.15 2.81 ± 0.10 2.87 ± 0.17 2.92 ± 0.14 0.593
F (n = 5) 2.45 ± 0.09 2.38 ± 0.07 2.35 ± 0.05 2.43 ± 0.07 0.114
Kidney M (n = 5) 0.75 ± 0.02 0.75 ± 0.03 0.76 ± 0.02 0.76 ± 0.03 0.930
F (n = 5) 0.69 ± 0.03 0.70 ± 0.02 0.70 ± 0.05 0.72 ± 0.04 0.639
Spleen M (n = 5) 0.19 ± 0.02 0.19 ± 0.02 0.18 ± 0.03 0.19 ± 0.02 0.937
F (n = 5) 0.18 ± 0.02 0.18 ± 0.02 0.18 ± 0.02 0.19 ± 0.02 0.835
Lung M (n = 5) 0.40 ± 0.02 0.40 ± 0.02 0.39 ± 0.02 0.42 ± 0.01 0.241
F (n = 5) 0.49 ± 0.02 0.48 ± 0.02 0.49 ± 0.01 0.50 ± 0.02 0.536
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
Table 4 Satellite group/ Relative organs weight (g%) of rats in
the sub-acute oral toxicity test
Satellite group/ Relative organs weight (g) of rats in the sub-acute oral
toxicity test
Sex Control DC 1500 mg/kg P value
Heart M 0.34 ± 0.03 0.34 ± 0.02 0.797
F 0.38 ± 0.01 0.38 ± 0.01 0.493
Liver M 2.73 ± 0.09 2.76 ± 0.08 0.508
F 2.59 ± 0.13 2.64 ± 0.12 0.524
Kidney M 0.76 ± 0.02 0.75 ± 0.02 0.655
F 0.72 ± 0.03 0.72 ± 0.03 0.696
Spleen M 0.19 ± 0.01 0.19 ± 0.01 0.370
F 0.20 ± 0.02 0.20 ± 0.01 0.832
Lung M 0.40 ± 0.02 0.38 ± 0.02 0.308
F 0.50 ± 0.02 0.50 ± 0.01 0.722
Values expressed as a mean ± standard deviation. n= 5. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
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During the evaluation of the toxic characteristics of
medicinal plants, an initial assessment of toxic manifes-
tations is one of the initial screening experiments per-
formed with all compounds. In addition, Data from the
acute toxicity study may serve as the basis for classifica-
tion and labelling of the test material [31]. Thus, the
current study was assumed to evaluate and focus on the
acute and sub-acute toxicity of DC resin methanol ex-
tract in an animal model.
The oral route administration is the most useful and
normally used one while doing toxicity study. The ab-
sorption may be slow; however, this methodology ex-
penses less and is painless to the animals. As the crude
extracts administered orally, the animals need to fast be-
fore administering the material because food and other
chemicals within the digestive system may have an effect
on the reaction(s) of the tested materials. All the proce-
dures were performed based on the appropriate OECD
guideline [32].
Test method with a starting dose of 300 mg/kg body
weight primarily used in situations where the investiga-
tor has no information indicating that the test material
is likely to be toxic [23]. In this study, the rats in control
and DC treated groups administrated with the vehicle
and crude extracts, respectively. From the experiment
performed, the starting dose of 300 mg/kg body weight
has revealed no mortality in the experimental animals.
Thus, the next higher dose of 2000 mg/kg body weight
selected as described in the OECD Guidelines 423. The
rats monitored daily until the last day of the experiment
(day 14th) for any toxic signs and mortality. The clinical
symptom is one amongst the most important observa-
tions to indicate the toxicity effects on organs within the
treated groups [7]. During the 14 days of acute toxicity
assessment period, all rats orally administrated with DC
resin methanol extract at a single dose of 300 mg/kg and
2000 mg/kg showed no obvious signs of distress, and
there were no noticeable symptoms of either toxicity or
deaths. All of the rats showed no significant changes in
wellness parameters. Physical appearance features such
as skin, fur, eyes, mucous membrane, salivation, behav-
ioural pattern, the sleep of the animals in control and
DC treated groups (300 mg and 2000 mg) of DC extract
were found to be normal. Lethargy, tremors, diarrhoea
and coma did not occur in any of the animals. Moreover,
the body weight of the rats showed an increase in both
control and DC treated groups without significant
Table 5 (A and B) Food consumption (g) of rats in acute and sub-acute oral toxicity tests
A Acute oral toxicity
Sex Control DC 300 mg/kg DC 2000 mg/kg P value
Week 1 F (n = 3) 64.68 ± 2.80 63.43 ± 2.87 59.14 ± 14.67 0.089
Week 2 F (n = 3) 66.16 ± 2.89 67.05 ± 5.14 63.74 ± 2.15 0.236
B Sub-acute oral toxicity
Sex Control DC 500 mg/kg DC 1000 mg/kg DC 1500 mg/kg P value
Week 1 M (n = 5) 81.75 ± 1.21 81.15 ± 2.17 80.99 ± 2.55 79.26 ± 2.42 0.189
F (n = 5) 74.87 ± 2.59 72.99 ± 1.63 72.47 ± 2.28 71.55 ± 2.80 0.089
Week 2 M (n = 5) 84.52 ± 1.13 83.93 ± 0.93 83.80 ± 1.77 82.59 ± 1.11 0.061
F (n = 5) 78.69 ± 3.26 77.56 ± 3.21 75.99 ± 3.58 74.66 ± 4.64 0.220
Week 3 M (n = 5) 88.05 ± 2.54 87.92 ± 2.07 86.10 ± 1.94 85.19 ± 2.58 0.075
F (n = 5) 86.55 ± 3.64 86.15 ± 3.11 85.17 ± 3.75 83.21 ± 3.68 0.320
Week 4 M (n = 5) 91.84 ± 1.60 91.08 ± 0.79 90.30 ± 1.26 90.23 ± 1.11 0.069
F (n = 5) 88.69 ± 3.66 87.35 ± 3.26 87.75 ± 3.32 87.04 ± 2.77 0.798
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
Table 6 Satellite group/ Food consumption (g) of rats in the
sub-acute oral toxicity test
Satellite group/ food consumption in oral sub-acute toxicity test
Sex Control DC 1500 mg/kg P value
Week 1 M (n = 5) 81.92 ± 1.44 79.30 ± 3.81 0.113
F (n = 5) 73.05 ± 3.11 71.26 ± 1.96 0.221
Week 2 M (n = 5) 84.60 ± 2.38 82.68 ± 1.56 0.099
F (n = 5) 73.68 ± 2.27 72.77 ± 1.93 0.435
Week 3 M (n = 5) 89.75 ± 1.96 87.72 ± 1.69 0.059
F (n = 5) 81.89 ± 3.76 78.62 ± 4.60 0.170
Week 4 M (n = 5) 91.96 ± 0.66 91.07 ± 0.93 0.061
F (n = 5) 83.55 ± 2.00 82.43 ± 1.59 0.265
Week 5 M (n = 5) 92.96 ± 1.63 91.87 ± 1.80 0.256
F (n = 5) 85.81 ± 1.98 83.92 ± 3.91 0.179
Week 6 M (n = 5) 101.90 ± 3.70 100.25 ± 2.85 0.366
F (n = 5) 86.55 ± 3.82 83.07 ± 4.73 0.155
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
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difference seen (Table 1 A); this indicates that the DC
resin methanol extract has no adverse effect on the
growth of the animals.
This study estimated that DC resin methanol extract
does not cause acute toxicity effects and no rat has died.
Based on OECD guidelines 423 (Annex 2), the results of
this test allow the substance to be ranked and classified
according to the Globally Harmonized System of Classi-
fication and Labelling of Chemicals. Thus, the DC resin
methanol extract can be classified as category 5 with low
acute toxicity hazard, which was the lowest toxicity class
[23]. Therefore, it can be concluded that DC resin
methanol extract is tolerated up to 2000 mg/kg body
weight when administered at a single dose. In a like
manner, a study performed by R Ramaswamy, N
Prathyusha, R Saranya, H Sumathy, K Mohanavalli, R
Priya, J Venkhatesh, C Babu, K Manickavasakam and S
Thanikachalam [28] using Nuna Kadugu (a Siddha medi-
cine prepared from leaves and fruits of Morinda
Pubescens) revealed that Nuna Kadugu can be classified
under category-5 when administered at single dose
2000 mg/kg in accordance with Globally Harmonised
System of Classification and Labelling of Chemicals, and
this provides a direct relevance for protecting human
and animal health.
Acute toxicity information is of limited clinical appli-
cation because cumulative toxic effects do occur even at
very low doses. Consequently, multiple dose studies are
typically useful in evaluating the safety profile of phyto-
medicines. Therefore, sub-acute (Repeated dose 28-day
Table 7 (A and B) Water intake (ml) of rats in the acute and sub-acute oral toxicity tests
A Acute oral toxicity
Sex Control DC 300 mg/kg DC 2000 mg/kg P value
Week 1 F (n = 3) 102.56 ± 1.27 104.03 ± 1.78 104.34 ± 2.12 0.157
Week 2 F (n = 3) 102.54 ± 0.97 104.00 ± 1.77 103.93 ± 2.01 0.199
B Sub-acute oral toxicity
Sex Control DC 500 mg/kg DC 1000 mg/kg DC 1500 mg/kg P value
Week 1 M (n = 5) 123.18 ± 1.39 128.09 ± 2.34 128.03 ± 1.91 127.40 ± 2.11 0.000*
F (n = 5) 122.39 ± 0.42 125.51 ± 0.50 125.48 ± 0.37 125.46 ± 0.53 0.000*
Week 2 M (n = 5) 124.06 ± 1.17 127.31 ± 1.50 127.44 ± 1.48 127.97 ± 1.85 0.000*
F (n = 5) 123.33 ± 0.55 125.68 ± 0.45 125.99 ± 0.41 125.87 ± 0.41 0.000*
Week 3 M (n = 5) 125.23 ± 0.96 127.99 ± 1.33 127.98 ± 1.80 127.86 ± 1.69 0.004*
F (n = 5) 124.44 ± 0.49 127.29 ± 0.66 127.12 ± 0.61 127.16 ± 0.77 0.000*
Week 4 M (n = 5) 125.89 ± 0.78 128.29 ± 1.95 128.54 ± 1.22 128.34 ± 1.61 0.007*
F (n = 5) 124.99 ± 0.50 127.28 ± 0.86 127.36 ± 0.63 127.56 ± 0.61 0.000*
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value. Numbers in bold indicate a statistically significant difference
Table 8 Tukey test of water intake (ml) of male and female rats in sub-acute oral toxicity test
Dependent variable (I) water intake (J) water intake Mean difference (I-J) in male rat P value Mean difference (I-J) in female rat P value
Week 1 Control DC 500 mg/kg −4.91 ± 1.05 0.001* −3.12 ± 0.24 0.000*
DC 1000 mg/kg −4.86 ± 1.05 0.001* −3.09 ± 0.24 0.000*
DC 1500 mg/kg −4.23 ± 1.05 0.003* −3.07 ± 0.24 0.000*
Week 2 Control DC 500 mg/kg −3.25 ± 0.81 0.003* −2.35 ± 0.25 0.000*
DC 1000 mg/kg −3.38 ± 0.81 0.002* −2.67 ± 0.25 0.000*
DC 1500 mg/kg −3.91 ± 0.81 0.000* −2.54 ± 0.25 0.000*
Week 3 Control DC 500 mg/kg −2.77 ± 0.79 0.009* −2.85 ± 0.34 0.000*
DC 1000 mg/kg −2.75 ± 0.79 0.010* −2.68 ± 0.34 0.000*
DC 1500 mg/kg −2.63 ± 0.79 0.014* −2.72 ± 0.34 0.000*
Week 4 Control DC 500 mg/kg −2.40 ± 0.78 0.025* −2.29 ± 0.35 0.000*
DC 1000 mg/kg −2.65 ± 0.78 0.012* −2.37 ± 0.35 0.000*
DC 1500 mg/kg −2.45 ± 0.78 0.021* −2.57 ± 0.35 0.000*
Values expressed as a mean ± Standard Error. n = 5
*p-value less than 0.05, (p < 0.05) significant value. Numbers in bold indicate a statistically significant difference
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Table 9 Satellite group/ Water intake (ml) of rats in the
sub-acute oral toxicity test at each week
Satellite group/ Water intake (ml) of rats in the sub-acute oral toxicity
test at each week
Sex Control DC 1500 mg/kg P value
Week 1 M 124.39 ± 0.41 125.86 ± 0.85 0.001*
F 121.24 ± 1.79 123.59 ± 1.96 0.037*
Week 2 M 124.87 ± 0.64 127.14 ± 1.09 0.000*
F 123.33 ± 1.85 125.03 ± 0.76 0.044*
Week 3 M 126.40 ± 0.87 128.30 ± 1.37 0.009*
F 123.80 ± 0.95 125.80 ± 1.00 0.002*
Week 4 M 127.48 ± 0.95 128.89 ± 1.21 0.032*
F 124.53 ± 1.10 125.94 ± 1.01 0.027*
Week 5 M 128.38 ± 1.11 129.03 ± 0.86 0.244
F 125.68 ± 0.99 125.97 ± 0.68 0.538
Week 6 M 128.94 ± 1.28 129.30 ± 1.34 0.620
F 126.48 ± 0.90 126.58 ± 0.68 0.825
Values expressed as a mean± standard deviation. n= 5. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value. Numbers in bold indicate a
statistically significant difference
Table 10 (A and B) Hematological parameters of the rats in acute and sub-acute oral toxicity tests
A Acute oral toxicity
Hematological Parameters Sex Control DC 300 mg/kg DC2000 mg/kg P value
HGB (g/L) F (n = 3) 153.00 ± 10.00 145.50 ± 9.50 149.33 ± 17.95 0.789
WBC (10^9/L) F (n = 3) 6.83 ± 0.23 7.77 ± 0.38 8.05 ± 0.75 0.057
Neutrophil (10^9/L) F (n = 3) 0.55 ± 0.13 0.56 ± 0.07 0.58 ± 0.14 0.961
Lymphocyte (10^9/L) F (n = 3) 6.39 ± 0.87 6.72 ± 1.15 7.29 ± 0.52 0.498
Monocyte (10^9/L) F (n = 3) 0.14 ± 0.03 0.15 ± 0.02 0.18 ± 0.3 0.228
Eosinophil (10^9/L) F (n = 3) 0.08 ± 0.02 0.10 ± 0.02 0.11 ± 0.02 0.125
Basophil (10^9/L) F (n = 3) 0.02 ± 0.01 0.03 ± 0.02 0.03 ± 0.02 0.531
B Sub-acute oral toxicity
Hematological Parameters Sex Control DC 500 mg/kg DC1000 mg/kg DC1500 mg/kg P value
HGB (g/L) M (n = 5) 149.40 ± 6.47 148.80 ± 5.40 150.40 ± 12.72 156.80 ± 12.91 0.575
F (n = 5) 156.40 ± 5.81 148.80 ± 7.82 150.60 ± 3.85 153.40 ± 5.81 0.243
WBC (10^9/L) M (n = 5) 9.22 ± 1.03 9.30 ± 2.45 9.46 ± 1.33 9.56 ± 3.67 0.996
F (n = 5) 6.86 ± 0.59 7.40 ± 1.15 7.38 ± 0.93 7.82 ± 0.81 0.431
Neutrophil (10^9/L) M (n = 5) 0.98 ± 0.12 1.01 ± 0.16 1.03 ± 0.18 1.14 ± 0.30 0.626
F (n = 5) 0.81 ± 0.21 0.77 ± 0.11 0.87 ± 0.17 0.89 ± 0.14 0.646
Lymphocyte (10^9/L) M (n = 5) 9.66 ± 2.12 9.64 ± 1.67 10.39 ± 1.99 10.77 ± 2.08 0.753
F (n = 5) 8.22 ± 1.07 8.44 ± 1.22 8.67 ± 1.00 9.20 ± 1.14 0.564
Monocyte (10^9/L) M (n = 5) 0.16 ± 0.02 0.15 ± 0.02 0.17 ± 0.04 0.19 ± 0.04 0.411
F (n = 5) 0.17 ± 0.03 0.16 ± 0.03 0.18 ± 0.02 0.18 ± 0.03 0.623
Eosinophil (10^9/L) M (n = 5) 0.08 ± 0.02 0.09 ± 0.02 0.10 ± 0.02 0.10 ± 0.03 0.388
F (n = 5) 0.08 ± 0.01 0.09 ± 0.02 0.07 ± 0.03 0.10 ± 0.02 0.215
Basophil (10^9/L) M (n = 5) 0.06 ± 0.2 0.04 ± 0.03 0.04 ± 0.03 0.04 ± 0.03 0.537
F (n = 5) 0.02 ± 0.02 0.03 ± 0.02 0.03 ± 0.02 0.04 ± 0.02 0.397
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
Table 11 Hematological parameters in sub-acute oral toxicity
test in Satellite group
Satellite group/ Hematological parameters in sub-acute oral toxicity test
Sex Control DC 1500 mg/kg P value
HGB (g/L) M 152.40 ± 6.80 153.20 ± 7.46 0.863
F 155.00 ± 6.82 154.80 ± 5.97 0.961
WBC (10^9/L) M 9.30 ± 1.36 10.76 ± 1.23 0.112
F 6.70 ± 0.72 6.74 ± 0.60 0.926
Neutrophil (10^9/L) M 1.08 ± 0.13 1.31 ± 0.23 0.084
F 1.25 ± 0.11 1.33 ± 0.11 0.295
Lymphocyte (10^9/L) M 9.77 ± 1.07 11.25 ± 1.41 0.098
F 9.29 ± 0.95 9.31 ± 0.70 0.977
Monocyte (10^9/L) M 0.21 ± 0.06 0.23 ± 0.07 0.649
F 0.22 ± 0.05 0.23 ± 0.03 0.773
Eosinophil (10^9/L) M 0.10 ± 0.01 0.10 ± 0.02 0.856
F 0.09 ± 0.02 0.10 ± 0.03 0.596
Basophil (10^9/L) M 0.03 ± 0.02 0.04 ± 0.03 0.636
F 0.02 ± 0.01 0.03 ± 0.01 0.545
Values expressed as a mean ± standard deviation. n = 5. Sex (male, M and
female, F). *p-value less than 0.05, (p < 0.05) significant value
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oral toxicity) test has been used. Body weight changes
are an indicator of adverse side effects [33], and lose
more than 20% of the animal body weight is regarded as
critical and has been defined as one of the humane end-
points in several international guidelines [34, 35]. In this
study, all rats in the vehicle control and DC treated
groups were gaining weight; however, there were no sig-
nificant changes in body weight gain between the groups
in a sub-acute oral test at each week (Table 1 B). More-
over, no significant change detected between the groups
in both acute and sub-acute oral toxicity test regarding
the ROW (Table 3 A and B). In satellite groups, nothing
abnormal detected, and no significant difference was
showed in body weight gain and ROW (Tables 2 and 4)
respectively.
Sub-acute oral toxicity test was conducted to evaluate
the adverse effects of test medicinal plant DC resin
methanol extract and was carried out to provide infor-
mation about the possible health threats that probable
to arise from sub-acute exposure over a period of time,
Table 12 Biochemical parameters of the rats in acute oral toxicity test
Biochemical parameters Sex Groups P value
Control DC 300 mg/kg DC 2000 mg/kg
Urea (mmol/L) F 3.80 ± 0.53 4.00 ± 0.62 4.13 ± 0.29 0.727
Creatinine (umol/L) F 32.67 ± 1.53 32.00 ± 4.58 31.67 ± 1.53 0.920
Albumin (g/L) F 40.67 ± 4.04 37.67 ± 3.51 36.67 ± 1.53 0.350
Globulin (g/L) F 24.00 ± 1.00 22.33 ± 2.08 20.00 ± 2.65 0.128
Total bilirubin (umol/L) F 2.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 –
Conjugate bilirubin (umol/L) F 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 –
ALP (U/L) F 166.33 ± 4.73 164.67 ± 6.03 177.33 ± 7.02 0.081
ALT (U/L) F 24.67 ± 1.53 25.67 ± 1.15 26.67 ± 1.53 0.296
AST (U/L) F 96.00 ± 9.17 99.67 ± 7.57 107.33 ± 3.06 0.216
Values expressed as a mean ± standard deviation, n = 3
*p-value less than 0.05, (p < 0.05) significant value
Table 13 Biochemical parameters of the rats in sub-acute oral toxicity test
Biochemical parameters Groups P value
Sex Control DC 500 mg/kg DC 1000 mg/kg DC 1500 mg/kg
Urea (mmol/L) M 3.76 ± 0.59 3.92 ± 0.34 4.14 ± 0.38 4.18 ± 0.51 0.466
F 3.90 ± 0.74 4.06 ± 0.44 3.97 ± 0.69 4.16 ± 1.24 0.963
Creatinine (umol/L) M 24.20 ± 4.15 24.00 ± 2.55 23.60 ± 6.91 27.20 ± 4.15 0.615
F 28.60 ± 3.05 28.40 ± 2.70 27.40 ± 2.70 28.80 ± 1.92 0.839
Albumin (g/L) M 35.00 ± 2.24 34.60 ± 1.14 36.20 ± 5.26 34.60 ± 1.67 0.817
F 35.00 ± 1.58 34.60 ± 2.40 36.20 ± 2.17 34.00 ± 2.55 0.470
Globulin (g/L) M 20.60 ± 1.14 21.00 ± 1.58 21.20 ± 1.48 21.20 ± 1.30 0.890
F 22.40 ± 1.14 21.80 ± 1.10 22.80 ± 1.30 21.20 ± 1.48 0.245
Total bilirubin (umol/L) M 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 –
F 2.00 ± 0.00 2.00 ± 0.00 2.00 ± 0.00 2.00 ± 0.00 –
Conjugate bilirubin (umol/L) M 1.40 ± 1.14 1.00 ± 0.00 0.40 ± 0.55 1.00 ± 1.22 0.379
F 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 –
ALP (U/L) M 216.20 ± 16.99 218.40 ± 12.70 222.40 ± 18.51 236.40 ± 12.74 0.203
F 204.20 ± 14.64 210.80 ± 29.52 209.60 ± 23.70 197.60 ± 16.33 0.769
ALT (U/L) M 29.60 ± 3.29 29.40 ± 1.52 29.60 ± 2.30 32.00 ± 2.83 0.356
F 23.40 ± 3.21 23.60 ± 3.05 25.40 ± 3.36 26.80 ± 1.64 0.243
AST (U/L) M 104.80 ± 6.69 106.00 ± 3.94 105.40 ± 5.55 109.00 ± 4.95 0.623
F 99.60 ± 7.40 103 ± 2.30 103.60 ± 3.44 104.60 ± 2.41 0.320
Values expressed as a mean ± standard deviation, n = 5. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value
Al-Afifi et al. BMC Complementary and Alternative Medicine  (2018) 18:50 Page 10 of 14
the possibilities of cumulative effects, and an estimate of
the dose at which there is no observed adverse effect.
Evaluation of safety margin between different dose level
that produces the therapeutic effect and that which pro-
duces the adverse effects is necessary. Evaluation of
safety is exactly to provide benefit to risk assessment.
Animal experimental model is the only method that can
assess this matter [36]. Determination of food consump-
tion is an important to study the safety of a product with
therapeutic purpose as proper intake of nutrients is
Table 14 Biochemical parameters of the rats in satellite group for subacute oral toxicity test
Biochemical parameters Satellite group P value
Sex Control DC 1500 mg/kg
Urea (mmol/L) M 3.78 ± 0.34 3.92 ± 0.48 0.608
F 3.96 ± 0.70 4.06 ± 0.17 0.765
Creatinine (umol/L) M 25..00 ± 3.87 26.40 ± 3.78 0.579
F 29.40 ± 3.05 27.20 ± 3.96 0.354
Albumin (g/L) M 35.20 ± 1.30 34.40 ± 1.67 0.423
F 34.20 ± 2.77 32.40 ± 3.36 0.382
Globulin (g/L) M 20.20 ± 0.84 19.40 ± 1.34 0.290
F 22.00 ± 1.58 21.20 ± 1.30 0.408
Total bilirubin (umol/L) M 1.00 ± 0.00 1.00 ± 0.00 –
F 2.00 ± 0.00 2.00 ± 0.00 –
Conjugate bilirubin (umol/L) M 1.00 ± 0.00 1.00 ± 0.00 –
F 1.00 ± 0.00 1.00 ± 0.00 –
ALP (U/L) M 223.60 ± 29.98 226.20 ± 28.35 0.891
F 184.40 ± 29.11 190.40 ± 29.21 0.753
ALT (U/L) M 31.00 ± 3.39 30.00 ± 3.81 0.673
F 25.20 ± 1.79 25.60 ± 2.07 0.752
AST (U/L) M 107.00 ± 6.04 111.40 ± 5.94 0.279
F 103.40 ± 3.29 105.00 ± 2.74 0.427
Values expressed as a mean ± standard deviation, n = 5. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value




Fig. 1 Photomicrograph of vital organs in acute oral toxicity (H & E Stain, ×100). Liver: black arrow – portal vein; white arrow – portal triad.
Kidney: black arrow – cortex; white arrow – medulla. Heart: black arrow – myocardium; white arrow – blood vessel. Lung: Black arrow – alveoli;
white arrow – bronchiole. Spleen: Black arrow – white pulp, white arrow – red pulp
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essential to the physiological status of the animal and
give a good impression of the appropriate response to
the treatment [37].
For food consumption, no significant changes ob-
served in all groups (vehicle and DC extract treated
groups) in both acute and subacute oral toxicity tests
and this reveals that it did not adversely affect the basic
metabolic processes of the experimental animals. On the
other hand, water intake showed more in the DC resin
methanol extract treated groups than the control, with a
significant difference showed in sub-acute oral toxicity
test (Table 8) and satellite group (Table 9) for both male
and female rats during the administration period. This
result could be refereed to that DC resin extract can
produce vasodilatation (hypotension) due to relaxation
of smooth muscles of blood vessels [9] which in turn
stimulate thirst and increase water intake [38].
Hematological and biochemistry data play a major role
in determining the toxicity induced by drugs [39]. Blood
parameters analysis is appropriate to risk evaluation as
the hematological system has a higher prognostic value
for toxicity [40]. Blood serves as the main medium of
transport for many drugs and xenobiotics in the body
and for that reason components of the blood exposed to
substantial concentrations of toxic compounds. Damage
to and destruction of the blood cells are inimical to nor-
mal functioning of the body both in humans and animals
[41]. In the present study, the hematological parameters
data indicated that DC resin methanol extract did not
affect blood cells production as there was no significant
difference between the groups in acute and sub-acute oral
toxicity tests (Table 10 A and B). In the satellite group, no
significant difference showed between the two groups
(Table 11). The change in hematological parameters was
within the normal range as showed elsewhere [39, 42].
Evaluation of Kidney and Liver function is important
in the assessment toxicity of plant extracts as both of
them are necessary for the survival of an organism [43].
In animal model toxicity studies, the serum level of cre-
atinine remains the most widely used laboratory test to
estimate renal function. It kept within a relatively stable
range as daily production and renal excretion are con-
tinuous in healthy mammals [44]. In the present study,
for kidney function test, two serum renal biochemical
parameters, namely urea and creatinine were analyzed as
previously mentioned [45]. There were no significant
changes observed in urea and creatinine levels between
the control and all doses of DC resin methanol extract
groups in both acute and sub-acute oral toxicity tests.
The enzymatic activity of the liver such as alanine ami-
notransferase (ALT), aspartate aminotransferase (AST)
and alkaline phosphatase (ALP) was studied to evaluate
liver malfunctions. Liver enzymes levels are usually
raised in acute hepatoxicity but tend to decrease with
prolonged intoxication due to damage to the liver [46].
In the present study, there were no significant
Fig. 2 Photomicrograph of vital organs in sub-acute oral toxicity (H & E Stain, × 100). Liver: black arrow – portal vein; white arrow – portal triad.
Kidney: black arrow – cortex; white arrow – medulla. Heart: black arrow – myocardium; white arrow – blood vessel. Lung: Black arrow – alveoli;
white arrow – bronchiole. Spleen: Black arrow – white pulp, white arrow – red pulp
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differences shown in the biochemical analysis in acute
and sub-acute oral toxicity test. The level was within
normal expected range for the rat species used in this
study. Bilirubin formed from the breakdown of
hemoglobin in the liver, spleen, and bone marrow. An
increase in tissue or serum bilirubin level occurs through
increased breakdown of RBC (hemolysis) or in the case
of hepatitis or bile duct obstruction (liver damage) [33].
Reduction in serum albumin level may suggest infection
or continuous loss of albumin [47]. Thus, the insignifi-
cant change in serum concentration of albumin and
globulin in control and DC treated groups at all doses
used in this study proposed that DC resin methanol ex-
tract not do damage in hepatocellular or secretory func-
tions of the liver which in turn indicated non-adverse
effects of the tested material. For biochemical analysis,
in the satellite group, there was no significant difference
has been noted which concluded that the tested material
(DC resin methanol extract) would not produce the de-
layed onset of toxicity.
The assessment of histopathological alterations in or-
gans considered as a basic test in the safety assessment
of tested materials [48]. No abnormality observed on
gross or histopathological evaluations of organs exam-
ined in this study. Histopathological findings of liver,
kidney, heart, lung and spleen were normal in all ani-
mals that given different doses of DC resin methanol ex-
tract in both acute and sub-acute oral toxicity tests.
However, to determine definitely the oral safety dose
and to detect any unanticipated variability of DC resin
methanol extract a sub-chronic toxicity and genotoxicity
studies might be required. Therefore, sub-chronic tox-
icity should be proceeded based on the oral doses of DC
resin methanol extract in sub-acute oral toxicity test.
Conclusions
In conclusion, according to Globally Harmonised Classifi-
cation System, DC resin methanol extract can be classified
as Category 5. In addition, we may conclude that DC resin
methanol extract is well tolerated up to the dose of
1500 mg/kg body weight administered daily for 28 days.
DC resin methanol extract did not cause any lethality or
produce any serum chemical alteration or important
histopathological signs. The present investigation demon-
strates, at least in part, the safety of DC resin methanol
extract suggesting its promising potential for pharmaceut-
ical uses.
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